EX-99.1 2 tm2218711d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $.01 par value per share, of CASI Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

 

Dated: June 21, 2022

 

  ETP GLOBAL FUND L.P.
   
  By: EMERGING TECHNOLOGY PARTNERS, LLC
General Partner
     
  By: /s/ Wei-Wu He, Ph.D.
    Name: Wei-Wu He, Ph.D.
    Title: Managing Member

 

  EMERGING TECHNOLOGY PARTNERS, LLC
   
  By: /s/ Wei-Wu He, Ph.D.
    Name: Wei-Wu He, Ph.D.
    Title: Managing Member

 

  ETP-BIOHEALTH FUND III L.P.
   
 

By: EMERGING TECHNOLOGY PARTNERS, LLC

General Partner

   
  By: /s/ Wei-Wu He, Ph.D.
    Name: Wei-Wu He, Ph.D.
    Title: Managing Member

 

  HUIYING MEMORIAL FOUNDATION
   
  By: /s/ Wei-Wu He, Ph.D.
    Name: Wei-Wu He, Ph.D.
    Title: President
       

  

  /s/ Wei-Wu He, Ph.D.
  Wei-Wu He, Ph.D.